Table 1.
Demographic characteristics in non-cachectic and cachectic cancer patients.
| Variable | Cancer patients | F/χ2 | ||
|---|---|---|---|---|
| Total | Non-cachectic | Cachectic | ||
| Number of patients | 203 | 94 | 109 | |
| Age in years | ||||
| Mean ± SD | 51.45 ± 9.7 | 52.0 ± 8.8 | 50.98 ± 10.4 | F = 2.9 |
| Median (Range) | 51 (20–77) | 52 (30–77) | 50 (20–75) | p = 0.46 |
| Gender [n (%)] | ||||
| Male | 107 (53) | 45 (48) | 62 (57) | χ2 = 1.6 |
| Female | 96 (47) | 49 (52) | 47 (43) | p = 0.208 |
| Cancer type [n (%)] | ||||
| Pancreatic cancer | 145 (71) | 76 (81) | 69 (63) | χ2 = 7.6 |
| NSCL cancer | 58 (29) | 18 (19) | 40 (37) | p = 0.008** |
| Comorbidities [n (%)] | ||||
| Negative | 100 (49) | 50 (54) | 50 (46) | χ2 = 1.2 |
| Positive | 103 (51) | 44 (46) | 59 (54) | p = 0.32 |
| No. of comorbidities [n (%)] | ||||
| One | 77 (75) | 34 (77) | 43 (73) | χ2 = 0.26 |
| >One | 26 (25) | 10 (23) | 16 (27) | p = 0.65 |
| Type of chemotherapy [n (%)] | ||||
| Xeloda | 145 (71) | 76 (81) | 69 (63) | χ2 = 7.6 |
| Gem/Cis | 58 (29) | 18 (19) | 40 (37) | p = 0.008** |
Data are given as mean ± SD, median (minimum–maximum), or n (%). Statistical analysis was carried out using the independent t-test and chi-square test; p ≤ 0.05.
Cis, cisplatin; F, independent t-test value; Gem, gemcitabine; n (%), number of cases within the group (percentage); NSCL, non-small cell lung; χ2, chi-square value.
**Significant difference at p ≤ 0.01.